Vos, A C W <br/><br/>
Risk of malignant lymphoma in patients with inflammatory bowel diseases: a Dutch nationwide study.  [electronic resource] 

 -  Inflammatory bowel diseases  Sep 2011 
 - 1837-45 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1536-4844 
<br/><br/><label>Standard No.: </label>10.1002/ibd.21582  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Azathioprine--adverse effects<br/>Case-Control Studies<br/>Child<br/>Child, Preschool<br/>Cohort Studies<br/>Epstein-Barr Virus Infections--complications<br/>Female<br/>Follow-Up Studies<br/>Herpesvirus 4, Human--pathogenicity<br/>Humans<br/>Immunosuppressive Agents--adverse effects<br/>Incidence<br/>Infant<br/>Infant, Newborn<br/>Inflammatory Bowel Diseases--complications<br/>Lymphoma--chemically induced<br/>Male<br/>Mercaptopurine--adverse effects<br/>Middle Aged<br/>Netherlands--epidemiology<br/>Prognosis<br/>Risk Factors<br/>Survival Rate<br/>Young Adult